Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jul 2, 2026, 4:00 PM EDT
1.097
+0.007 (0.63%)
After-hours: Jul 2, 2026, 6:23 PM EDT
Tempest Therapeutics Employees
Tempest Therapeutics had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% since the number was last reported on December 31, 2025.
Employees
5
Change
1
Growth
25.00%
Revenue / Employee
n/a
Profits / Employee
-$8,619,600
Market Cap
16.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 1 | 25.00% |
| Dec 31, 2025 | 4 | -20 | -83.33% |
| Dec 31, 2024 | 24 | 7 | 41.18% |
| Dec 31, 2023 | 17 | -2 | -10.53% |
| Dec 31, 2022 | 19 | 2 | 11.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Quince Therapeutics | 38 |
| Curis | 24 |
| Citius Pharmaceuticals | 23 |
| CalciMedica | 16 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| BioVie | 13 |
TPST News
- 8 days ago - Tempest Therapeutics registers to sell 2.43M shares of common stock for holders - TheFly
- 8 days ago - Tempest Therapeutics Registration statement: Registration filing - Filings
- 26 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - GlobeNewsWire
- 5 weeks ago - Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds - GlobeNewsWire
- 5 weeks ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 7 weeks ago - Tempest Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Tempest Therapeutics Earnings release: Q1 2026 - Filings